Oct. 23 at 9:49 PM
$GNLX Bryon Franzen
@bkfViking123
·
18m
$GNLX ... mkt cap EZ double on lung ... Olvi-Vec’s peak sales in lung cancer (SCLC + NSCLC) are most likely in the
$8B–
$12B range (base case) by 2032–2035, with a conservative floor of
$5B and an optimistic ceiling of
$16B.
data any day .... and ovarian 👍2026
